VeriMomIst eucalyptus globulus leaf extract in der Schwangerschaft sicher?
No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
Pregnancy-safe products containing eucalyptus globulus leaf extract
Related ingredients
Frequently asked questions
- Ist eucalyptus globulus leaf extract in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
- Ist eucalyptus globulus leaf extract während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Systemic absorption of volatile constituents is possible after topical application, so low but measurable exposure to lactating parent is plausible; no data indicate transfer to breastmilk or harmful effects in breastfed infants (sources: PubChem, PubMed, absence of ECHA harmonised classification).
- Ist eucalyptus globulus leaf extract sicher für Babyhaut?
- No specific data showing developmental or reproductive toxicity in infants from topical cosmetic use of the leaf extract and no harmonised CLP reproductive hazard. However, infant skin has higher permeability and eucalyptus materials (notably eucalyptus oil/1,8‑cineole) are reported in the literature to cause adverse effects in young children when ingested or used inappropriately; therefore dermal exposure is judged as moderate (adult exposure scored as low measurable, increased by +1 for infants). No infant‑specific mechanistic evidence of reproductive endocrine disruption was found (sources: PubMed reports of pediatric toxicity from eucalyptus oil ingestion, EWG entries; no ECHA Annex VI reproductive flags).
- Wie bewertet VeriMom eucalyptus globulus leaf extract?
- VeriMom bewertet eucalyptus globulus leaf extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu eucalyptus globulus leaf extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu eucalyptus globulus leaf extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.